Tweet by TheDaoIndex

Tweet

Related Content

Article Education/ACR/EULAR

Remission – Believe it or Not (10.2.2026)

Jack Cush, MD Oct 2, 2026
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.Upadacitinib is now approved in European Union to treat active polyarticular juvenile idiopathic arthritis (pJIA) ages > 2yrs for those not responding to 1+ DMARDs. In the USA, UPA is approved for pJIA &…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×